Brought to you by 
AstraZeneca may buy back Merck's rights from their old JV
02 Jul 2012
Executive Summary
In 2008, AstraZeneca PLC may be paying Merck about $3.3bn to buy back a group of drugs that have been sold in the US under the Astra Merck marketing and supply venture (signed in 1982 between Merck and the Swedish company Astra, one of AZ's predecessors).
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Joint Venture
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com